Literature DB >> 21629214

P5 medicine: a plus for a personalized approach to oncology.

Alessandra Gorini, Gabriella Pravettoni.   

Abstract

Mesh：

Year:  2011        PMID： 21629214     DOI： 10.1038/nrclinonc.2010.227-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  12 in total

Review 1.  Physician/patient decision aids for adjuvant therapy.

Authors:  Timothy J Whelan; Charles Loprinzi
Journal:  J Clin Oncol       Date:  2005-03-10       Impact factor: 44.544

2.  Informed consent for abdominal aortic aneurysm repair: assessing variations in surgeon opinion through a national survey.

Authors:  Loren Berman; Alan Dardik; Elizabeth H Bradley; Richard J Gusberg; Liana Fraenkel
Journal:  J Vasc Surg       Date:  2008-02       Impact factor: 4.268

3.  End-of-life decisions and advance directives in palliative care: a cross-cultural survey of patients and health-care professionals.

Authors:  R Voltz; A Akabayashi; C Reese; G Ohi; H M Sass
Journal:  J Pain Symptom Manage       Date:  1998-09       Impact factor: 3.612

4.  Personalized cancer medicine: era of promise and progress.

Authors:  Lisa Hutchinson
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

Review 5.  Predictive, personalized, preventive, participatory (P4) cancer medicine.

Authors:  Leroy Hood; Stephen H Friend
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

6.  Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients.

Authors:  A Ayres; P W Hoon; J B Franzoni; K B Matheny; P H Cotanch; S Takayanagi
Journal:  J Psychosom Res       Date:  1994-07       Impact factor: 3.006

7.  Patient comprehension of an interactive, computer-based information program for cardiac catheterization: a comparison with standard information.

Authors:  Alan R Tait; Terri Voepel-Lewis; Mauro Moscucci; Colleen M Brennan-Martinez; Robert Levine
Journal:  Arch Intern Med       Date:  2009-11-09

8.  Does a personalized approach improve patient satisfaction in thoracic oncology?

Authors:  Francesco Leo; Davide Radice; Florence Didier; Felipe Braga Carvalho; Ester Spacca; Marzia Madini; Chiara Esposito; Marianna Agnello; Sara Meneghin; Lorenzo Spaggiari
Journal:  Am J Manag Care       Date:  2009-06       Impact factor: 2.229

9.  Path model of multidimensional compliance with cancer therapy.

Authors:  J L Richardson; G Marks; C A Johnson; J W Graham; K K Chan; J N Selser; C Kishbaugh; Y Barranday; A M Levine
Journal:  Health Psychol       Date:  1987       Impact factor: 4.267

Review 10.  Decision aids for people facing health treatment or screening decisions.

Authors:  Annette M O'Connor; Carol L Bennett; Dawn Stacey; Michael Barry; Nananda F Col; Karen B Eden; Vikki A Entwistle; Valerie Fiset; Margaret Holmes-Rovner; Sara Khangura; Hilary Llewellyn-Thomas; David Rovner
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more
  21 in total

1.  How Do Patients Experience Individualized Medicine? A Qualitative Interview-based Study of Gene Expression Analyses in the Treatment of Breast Cancer.

Authors:  Sebastian Schleidgen; Sandra Thiersch; Rachel Wuerstlein; Georg Marckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-09-25       Impact factor: 2.915

2.  Genes, the environment and personalized medicine: We need to harness both environmental and genetic data to maximize personal and population health.

Authors:  Chris Carlsten; Michael Brauer; Fiona Brinkman; Jeffrey Brook; Denise Daley; Kelly McNagny; Mandy Pui; Diana Royce; Tim Takaro; Judah Denburg
Journal:  EMBO Rep       Date:  2014-06-06       Impact factor: 8.807

Review 3.  Systems Chronotherapeutics.

Authors:  Annabelle Ballesta; Pasquale F Innominato; Robert Dallmann; David A Rand; Francis A Lévi
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

4.  Ethical issues in oncology practice: a qualitative study of stakeholders' experiences and expectations.

Authors:  Chiara Crico; Virginia Sanchini; Paolo G Casali; Gabriella Pravettoni
Journal:  BMC Med Ethics       Date:  2022-06-30       Impact factor: 2.834

5.  From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and "augmented" medicine: some considerations on Salvatore Iaconesi's clinical story.

Authors:  Nicola Luigi Bragazzi
Journal:  Patient Prefer Adherence       Date:  2013-04-24       Impact factor: 2.711

6.  p-Medicine: From data sharing and integration via VPH models to personalized medicine.

Authors:  S Rossi; Ml Christ-Neumann; S Rüping; Fm Buffa; D Wegener; G McVie; Pv Coveney; N Graf; M Delorenzi
Journal:  Ecancermedicalscience       Date:  2011-08-17

7.  Development and psychometric testing of a breast cancer patient-profiling questionnaire.

Authors:  Alessandra Gorini; Ketti Mazzocco; Sara Gandini; Elisabetta Munzone; Gordon McVie; Gabriella Pravettoni
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-06-01

8.  Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.

Authors:  Aihua Li; David Meyre
Journal:  Curr Psychiatry Rev       Date:  2014-05

9.  Methods for nutrition monitoring in cancer patients: a cognitive perspective.

Authors:  C Lucchiari; M Masiero; G Pravettoni
Journal:  Ecancermedicalscience       Date:  2012-06-25

10.  Rethinking psychiatry with OMICS science in the age of personalized P5 medicine: ready for psychiatome?

Authors:  Nicola Luigi Bragazzi
Journal:  Philos Ethics Humanit Med       Date:  2013-07-12       Impact factor: 2.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.